AIMMAX Trademark

Trademark Overview

On Thursday, September 1, 2016, a trademark application was filed for AIMMAX with the United States Patent and Trademark Office. The USPTO has given the AIMMAX trademark a serial number of 87158039. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, February 9, 2024. This trademark is owned by AimMax Therapeutics, Inc.. The AIMMAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the fields of pharmaceuticals, drug products, biologics, [ antibodies, vaccines ] and therapeutics for the treatment and prevention of diseases
aimmax

General Information

Serial Number87158039
Word MarkAIMMAX
Filing DateThursday, September 1, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, February 9, 2024
Registration Number5413771
Registration DateTuesday, February 27, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2017

Trademark Statements

Pseudo MarkAIM MAX
Goods and ServicesResearch and development in the fields of pharmaceuticals, drug products, biologics, [ antibodies, vaccines ] and therapeutics for the treatment and prevention of diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 7, 2016
Primary Code042
First Use Anywhere DateMonday, December 18, 2017
First Use In Commerce DateMonday, December 18, 2017

Trademark Owner History

Party NameAimMax Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27713
Party NameAimMax Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChapel Hill, NC 27516
Party NameAimMax Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChapel Hill, NC 27516

Trademark Events

Event DateEvent Description
Friday, February 9, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, February 9, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, February 9, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 21, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, February 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 3, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 3, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, January 24, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 23, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 11, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, December 22, 2017USE AMENDMENT FILED
Thursday, January 11, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 22, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, July 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 9, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 17, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 16, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 15, 2016NON-FINAL ACTION E-MAILED
Thursday, December 15, 2016NON-FINAL ACTION WRITTEN
Monday, December 12, 2016ASSIGNED TO EXAMINER
Thursday, September 8, 2016NOTICE OF PSEUDO MARK E-MAILED
Wednesday, September 7, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 5, 2016NEW APPLICATION ENTERED

Related Keywords

aimmax therapeutics vaccines treatment prevention diseases antibodies biologics fields development pharmaceuticals